Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company (MEPIC), headquartered in Saudi Arabia, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic and branded medications. Established in the early 1990s, MEPIC has achieved significant milestones, including the expansion of its operational footprint across the Middle East and North Africa (MENA) region. MEPIC's core product offerings encompass a diverse range of therapeutic areas, including cardiovascular, anti-infective, and central nervous system medications. What sets MEPIC apart is its commitment to innovation and quality, ensuring that all products meet stringent international standards. With a strong market position, MEPIC has garnered recognition for its contributions to healthcare, making it a trusted name among healthcare professionals and patients alike.
DitchCarbon Score
How does Middle East Pharmaceutical Industries Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Middle East Pharmaceutical Industries Company's score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Middle East Pharmaceutical Industries Company's reported carbon emissions
Middle East Pharmaceutical Industries Company, headquartered in Saudi Arabia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that the company may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Middle East Pharmaceutical Industries to consider setting measurable climate goals and reporting their emissions to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Middle East Pharmaceutical Industries Company is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
